ArticleBone marrow transplantation2013

Comparable efficacy and lower cost of PBSC mobilization with intermediate-dose cyclophosphamide and G-CSF compared with plerixafor and G-CSF in patients with multiple myeloma treated with novel therapies.

F Awan et al.PubMed ↗Publisher ↗

No numbers read from the abstract.